Clinical RoundupFree UCLA researchers find patients with lung cancer most likely to respond to immunotherapy November 20, 2020Vol.46 No.44
Clinical RoundupFree AI can pick the best candidates for skin cancer treatment November 20, 2020Vol.46 No.44
Clinical RoundupFree Phase III trial shows decrease of chemotherapy-induced neutropenia November 20, 2020Vol.46 No.44
Clinical RoundupFree Neratinib in HER2-positive HR-negative early stage breast cancer shows DFS benefit vs. placebo November 20, 2020Vol.46 No.44
Clinical Roundup Keytruda + Lenvima meet PFS primary endpoint in advanced RCC November 13, 2020Vol.46 No.43
Clinical Roundup KEYNOTE-695 study: Tavo + Keytruda demonstrate 30% ORR in anti-PD-1 checkpoint refractory metastatic melanoma November 13, 2020Vol.46 No.43
Clinical Roundup State-level lung cancer screening rates are not aligned with lung cancer burden in the U.S. November 13, 2020Vol.46 No.43
Clinical Roundup Diagnostic imaging may increase risk of testicular cancer November 13, 2020Vol.46 No.43
Clinical Roundup JNCCN study evaluates cost-effectiveness of olaparib for metastatic pancreatic cancer November 13, 2020Vol.46 No.43
Clinical Roundup Research detects hormone-upregulated lncRNA within the lymphocyte-specific protein tyrosine kinase discovered in prostate cancer November 13, 2020Vol.46 No.43
